American Association of Blood Banks

Publications in OpenAlex of which a co-author is affiliated to this organization

All publications | By field | By subfield

All publications [Next]
Title DOI
https://doi.org/10.1111/j.1537-2995.2009.02279.x Emerging infectious disease agents and their potential threat to transfusion safety
https://doi.org/10.1046/j.1537-2995.2001.41121493.x Transfusion‐transmitted bacterial infectionin the United States, 1998 through 2000
https://doi.org/10.1097/aog.0000000000000869 National Partnership for Maternal Safety
https://doi.org/10.1182/blood-2016-05-715870 A trial of unrelated donor marrow transplantation for children with severe sickle cell disease
https://doi.org/10.1111/trf.13676 Trends in United States blood collection and transfusion: results from the 2013 AABB Blood Collection, Utilization, and Patient Blood Management Survey
https://doi.org/10.1111/trf.12802 The AABB recommendations for the C hoosing W isely campaign of the A merican B oard of I nternal M edicine
https://doi.org/10.1016/j.bbmt.2015.10.017 Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease
https://doi.org/10.1016/j.bbmt.2017.08.038 Relationship between Mixed Donor–Recipient Chimerism and Disease Recurrence after Hematopoietic Cell Transplantation for Sickle Cell Disease
https://doi.org/10.1111/trf.14359 Analysis of pediatric adverse reactions to transfusions
https://doi.org/10.1182/blood-2011-05-353490 Definitions of histocompatibility typing terms
https://doi.org/10.1111/jmwh.12345 National Partnership for Maternal Safety Consensus Bundle on Obstetric Hemorrhage
https://doi.org/10.1016/s2352-3026(19)30080-8 Revised international surveillance case definition of transfusion-associated circulatory overload: a classification agreement validation study
https://doi.org/10.1111/j.1537-2995.2010.02659.x A national survey of transfusion‐related acute lung injury risk reduction policies for platelets and plasma in the United States
https://doi.org/10.1097/01.aoa.0000482622.40786.7b National Partnership for Maternal Safety: Consensus Bundle on Obstetric Hemorrhage
https://doi.org/10.1016/s2214-109x(23)00564-8 Innovative blood transfusion strategies to address global blood deserts: a consensus statement from the Blood Delivery via Emerging Strategies for Emergency Remote Transfusion (Blood DESERT) Coalition
https://doi.org/10.1136/bmjopen-2021-055017 Status of hospital-based blood transfusion services in low-income and middle-income countries: a cross-sectional international survey
https://doi.org/10.1200/go.20.00606 C/Can City Engagement Process: An Implementation Framework for Strengthening Cancer Care in Cities in Low- and Middle-Income Countries
https://doi.org/10.1111/trf.12260 Restless legs syndrome, pica, and iron status in blood donors
https://doi.org/10.1016/j.bbmt.2014.07.009 Second Solid Cancers after Allogeneic Hematopoietic Cell Transplantation Using Reduced-Intensity Conditioning
https://doi.org/10.3324/haematol.2018.203919 Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors
https://doi.org/10.1111/1552-6909.12723 National Partnership for Maternal Safety: Consensus Bundle on Obstetric Hemorrhage
https://doi.org/10.1111/trf.13735 Red blood cell transfusion: 2016 clinical practice guidelines from AABB
https://doi.org/10.1016/j.humimm.2011.06.002 Definitions of histocompatibility typing terms: Harmonization of Histocompatibility Typing Terms Working Group
https://doi.org/10.1016/j.tmrv.2007.03.001 A Question of Clarity: Redesigning the American Association of Blood Banks Blood Donor History Questionnaire—A Chronology and Model for Donor Screening
https://doi.org/10.1016/j.hemonc.2019.08.001 Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I)
https://doi.org/10.1016/j.bbmt.2017.08.034 Ethical Challenges in Hematopoietic Cell Transplantation for Sickle Cell Disease
https://doi.org/10.1111/trf.15830 Development and validation of donor adverse reaction severity grading tool: enhancing objective grade assignment to donor adverse events
https://doi.org/10.1111/trf.16561 A survey of US hospitals on platelet inventory management, transfusion practice, and platelet availability
https://doi.org/10.1111/trf.16798 COVID‐19 and the impact on blood availability and transfusion practices in low‐ and middle‐income countries
https://doi.org/10.1111/trf.16520 Neonatal and pediatric blood bank practice in the United States : Results from the AABB pediatric transfusion medicine subsection survey
https://doi.org/10.1111/trf.14219 Obstetric hemorrhage and safe blood for transfusion in Ethiopia: the challenges of bridging the gap
https://doi.org/10.1186/s12967-024-05179-7 Mechanism of action, potency and efficacy: considerations for cell therapies
https://doi.org/10.1111/trf.18047 It is time to reconsider leukoreduction of whole blood for use in patients with life‐threatening hemorrhage
https://doi.org/10.1186/s12967-025-06253-4 Analysis of the measurements used as potency tests for the 31 US FDA-approved cell therapy products
https://doi.org/10.1056/nejm199011083231905 Prevalence of Human Immunodeficiency Virus Type 1 p24 Antigen in U.S. Blood Donors — An Assessment of the Efficacy of Testing in Donor Screening
https://doi.org/10.1046/j.1537-2995.1995.35695288769.x Prophylactic versus therapeutic platelet transfusion practices in hematology and/or oncology patients
https://doi.org/10.21307/immunohematology-2019-594 New protocols in serologic testing: a review of techniques to meet today’s challenges
https://doi.org/10.1111/trf.14948 International validation of harmonized definitions for complications of blood donations
https://doi.org/10.1111/j.1537-2995.2011.03071.x Boom or bust? Estimating blood demand and supply as the baby boomers age
https://doi.org/10.3109/14653240903511952 Developments in clinical cell therapy
https://doi.org/10.1111/trf.12862 Patient blood management: a primary theme in transfusion medicine
https://doi.org/10.1016/j.bbmt.2018.04.014 Easy-to-Read Informed Consent Form for Hematopoietic Cell Transplantation Clinical Trials: Results from the Blood and Marrow Transplant Clinical Trials Network 1205 Study
https://doi.org/10.1111/trf.12620 AABB validation study of the CDC 's N ational H ealthcare S afety N etwork H emovigilance M odule adverse events definitions protocol
https://doi.org/10.1097/aog.0000000000002463 Optimizing Blood Transfusion Practices Through Bundled Intervention Implementation in Patients With Gynecologic Cancer Undergoing Laparotomy
https://doi.org/10.1111/trf.12148 Survey of methods used to detect bacterial contamination of platelet products in the U nited S tates in 2011
https://doi.org/10.1111/trf.14591 Report of a workshop on ensuring sustainable access to safe blood in developing countries: International Blood Safety Forum, March 24, 2017
https://doi.org/10.1111/trf.15986 Transfusion services operations during the COVID ‐19 pandemic: Results from AABB survey
https://doi.org/10.5966/sctm.2012-0125 Concise Review: Immunologic Lessons From Solid Organ Transplantation for Stem Cell-Based Therapies
https://doi.org/10.1007/s10561-010-9219-z Coding and traceability: cells and tissues in North America
https://doi.org/10.1111/trf.16643 Hospital transfusion service operations during the SARS‐CoV ‐2 pandemic: Lessons learned from the AABB hospital survey in preparation for the next infectious disease outbreak
https://doi.org/10.1111/trf.13093 The growing role of AABB clinical practice guidelines in improving patient care
https://doi.org/10.1111/trf.17764 The 2023 AABB international guidelines for red blood cell transfusions: What is new?
https://doi.org/10.1111/trf.17880 How do transfusion services manage patients taking therapies such as anti‐ CD38 and anti‐ CD47 known to interfere with red blood cell compatibility testing?
https://doi.org/10.1046/j.1537-2995.1998.38198141508.x Current status of solvent/detergent‐treated frozen plasma
https://doi.org/10.1046/j.1537-2995.1996.361097017178.x Hypotensive reactions: a previously uncharacterized complication of platelet transfusion?
https://doi.org/10.1046/j.1537-2995.2001.41121486.x Evaluation of a reporting system for bacterial contamination of blood components in the United States
https://doi.org/10.1111/j.1537-2995.2005.00619.x Navigating the information technology highway: computer solutions to reduce errors and enhance patient safety
https://doi.org/10.1111/j.1537-2995.2006.00768.x Summary of the AABB Interorganizational Task Force on Bacterial Contamination of Platelets: Fall 2004 impact survey
https://doi.org/10.1111/j.1537-2995.2008.02048.x The impact of discontinuation of 7‐day storage of apheresis platelets (PASSPORT) on recipient safety: an illustration of the need for proper risk assessments
https://doi.org/10.1111/j.1537-2995.2007.01403.x AABB survey of transfusion‐related acute lung injury policies and practices in the United States
https://doi.org/10.1046/j.1537-2995.1994.34394196630.x The evolution of the current blood banking regulatory climate
https://doi.org/10.1111/j.1537-2995.2007.01457.x America finds hemovigilance!
https://doi.org/10.1111/trf.12609 Global health and transfusion medicine: education and training in developing countries
https://doi.org/10.1046/j.1537-2995.1993.33293158052.x National acceptability of American Association of Blood Banks Pediatric Hemotherapy Committee guidelines for auditing pediatric transfusion practices
https://doi.org/10.1007/s10877-013-9446-5 Potential of surface acoustic wave biosensors for early sepsis diagnosis
https://doi.org/10.1111/trf.15429 Safety incident reports associated with blood transfusions
https://doi.org/10.1111/trf.16792 Incorporating the entity of under‐transfusion into hemovigilance monitoring: Documenting cases due to lack of inventory
https://doi.org/10.1111/trf.16572 The safety of COVID ‐19 convalescent plasma donation: A multi‐institutional donor hemovigilance study
https://doi.org/10.1111/trf.16929 How do we obtain and maintain patient blood management certification?
https://doi.org/10.21307/immunohematology-2019-023 Hemovigilance and the Notify Library
https://doi.org/10.1111/trf.16054 Proceedings of the AABB blood center executive summit
https://doi.org/10.1182/blood.v126.23.619.619 A Multicenter Phase II Trial of Unrelated Donor Reduced Intensity Bone Marrow Transplantation for Children with Severe Sickle Cell Disease (SCURT): Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0601) Study
https://doi.org/10.1111/trf.17480 Whole blood in civilian transfusion practice: A review of the literature
https://doi.org/10.1002/jbm.a.34814 One‐dimensional patterning of cells in silicone wells via compression‐induced fracture
https://doi.org/10.1046/j.1537-2995.2001.41050713.x Selective transfusion protocols:errors and accidents waiting to happen
https://doi.org/10.1182/blood.v126.23.543.543 Results of a Multicenter Pilot Investigation of Bone Marrow Transplantation in Adults with Sickle Cell Disease (STRIDE)
https://doi.org/10.1111/trf.16960 U.S. cities will not meet blood product resuscitation standards during major mass casualty incidents: Results of a THOR‐AABB working party prospective analysis
https://doi.org/10.5858/1999-123-0468-wdtaoe What Do the Accreditation Organizations Expect?: American Association of Blood Banks
https://doi.org/10.1111/trf.12753 Training practices of hematopoietic progenitor cell–apheresis and –cord blood collection staff: analysis of a survey by the A lliance for H armonisation of C ellular T herapy A ccreditation
https://doi.org/10.1002/pbc.27105 Access to hematopoietic stem cell transplant for patients with sickle cell anemia
https://doi.org/10.1111/j.1537-2995.2010.02777.x AABB and FDA: a shared history of patient safety
https://doi.org/10.1016/j.jcyt.2015.08.006 Training practices of cell processing laboratory staff: analysis of a survey by the Alliance for Harmonization of Cellular Therapy Accreditation
https://doi.org/10.21307/immunohematology-2018-002 A brief overview of clinical significance of blood group antibodies
https://doi.org/10.1111/trf.15478 Transfusion‐associated circulatory overload risk mitigation: survey on hospital policies for compliance with AABB Standard 5.9.17
https://doi.org/10.1111/trf.17229 Demographics of first‐time donors returning for donation during the pandemic: COVID ‐19 convalescent plasma versus standard blood product donors
https://doi.org/10.1007/s10561-011-9282-0 West Nile Virus workshop: scientific considerations for tissue donors
https://doi.org/10.1016/j.bbmt.2015.11.407 Results of the Blood and Marrow Transplant Clinical Trials Network Study BMT CTN 0601: Scurt - a Multicenter Phase II Trial of Unrelated Donor Reduced Intensity Bone Marrow Transplantation (BMT) for Children with Severe Sickle Cell Disease
https://doi.org/10.1007/978-3-319-89866-7_4 Relationship Testing and Forensics
https://doi.org/10.1016/j.fsisyn.2025.100593 National Technology Validation and Implementation Collaborative (NTVIC): Updated guidelines for establishing Forensic Investigative Genetic Genealogy (FIGG) programs
https://doi.org/10.1111/trf.14950 Impact of changes to donor hemoglobin criteria on the rate of donor deferral
https://doi.org/10.1016/j.tmrv.2022.06.006 AABB's response to ‘Gender Inequities in Transfusion Medicine Society Recognition Awards’
https://doi.org/10.1046/j.1537-2995.1991.31591263204.x Screening potential blood donors at risk for human immunodeficiency virus
https://doi.org/10.1046/j.1537-2995.1989.29789369672.x Prevalence of antibodies to human immunodeficiency virus type 1 among blood donors prior to screening, The Transfusion Safety Study/NHLBI Donor Repository
https://doi.org/10.1046/j.1537-2995.1990.30190117635.x Directed and limited‐exposure blood donations for infants and children
https://doi.org/10.1046/j.1537-2995.1987.27287150201.x Look‐back: preliminary experience of AABB members. American Association of Blood Banks
https://doi.org/10.1046/j.1537-2995.1993.33994025029.x Blood donor‐, apheresis‐, and transfusion‐related activities: results of the 1991 American Association of Blood Banks Institutional Membership Questionnaire
https://doi.org/10.1046/j.1537-2995.1995.35495216087.x Procurement and transfusion of human immunodeficiency virus‐positive or untested autologous blood units: issues and concerns: a report prepared by the Autologous Transfusion Committee of the American Association of Blood Banks
https://doi.org/10.1111/j.1751-2824.2008.00168.x Biovigilance initiatives
https://doi.org/10.1111/j.1537-2995.2008.01730.x A letter from Mozambique
https://doi.org/10.1111/j.1537-2995.2008.01729.x A letter from Tanzania